Uncertain Diagnostic Accuracy of Self-Monitoring Vision at Home

To the Editor We recently reviewed the article by Korot et al, which reported on enablers and barriers when deploying the My Vision Track vision home-monitoring application (MVT) to patients monitored for anti –vascular endothelial growth factor treatment. We noted that the authors reported sensitivity and specificity estimates for the application of 84.6% and 88.5%, respectively. Although not the focus of the original article, this letter addresses these estimates.

Source: JAMA Ophthalmology - April 1, 2024 Category: Opthalmology Source Type: research